MENU
+Compare
GSEU
ETF ticker: NYSE ARCA
AS OF
Jan 17 closing price
Price
$35.42
Change
+$0.13 (+0.37%)
Net Assets
86.26M

GSEU stock forecast, quote, news & analysis

Category: @Europe Stock
GSEU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for GSEU with price predictions
Jan 08, 2025

GSEU's RSI Indicator climbs out of oversold territory

The RSI Indicator for GSEU moved out of oversold territory on December 23, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In of the 32 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 06, 2025. You may want to consider a long position or call options on GSEU as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GSEU just turned positive on January 06, 2025. Looking at past instances where GSEU's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GSEU advanced for three days, in of 348 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GSEU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Boeing Company (NYSE:BA), BP plc (NYSE:BP), Allergan plc (NYSE:AGN), JD.com (NASDAQ:JD), Suncor Energy (NYSE:SU), Prudential Financial (NYSE:PRU), Newmont Corp (NYSE:NEM), Archer Daniels Midland Company (NYSE:ADM).

Industry description

The investment seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the Goldman Sachs ActiveBeta® Europe Equity Index (the "index"). The index is designed to deliver exposure to equity securities of developed markets issuers in Europe. The fund seeks to achieve its investment objective by investing at least 80% of its assets (exclusive of collateral held from securities lending) in securities included in its underlying index, in depositary receipts representing securities included in its underlying index and in underlying stocks in respect of depositary receipts included in its underlying index.

Market Cap

The average market capitalization across the Goldman Sachs ActiveBeta® Europe Eq ETF ETF is 38.16B. The market cap for tickers in the group ranges from 64.65K to 380.18B. ASML holds the highest valuation in this group at 380.18B. The lowest valued company is BAYN at 64.65K.

High and low price notable news

The average weekly price growth across all stocks in the Goldman Sachs ActiveBeta® Europe Eq ETF ETF was 2%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was -3%. JD experienced the highest price growth at 18%, while SALM experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Goldman Sachs ActiveBeta® Europe Eq ETF ETF was 2%. For the same stocks of the ETF, the average monthly volume growth was -9% and the average quarterly volume growth was 58%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 49
Price Growth Rating: 52
SMR Rating: 66
Profit Risk Rating: 63
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
GSEU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category EuropeStock

Profile
Fundamentals
Details
Category
Europe Stock
Address
Goldman Sachs ETF Trust200 West StreetNew York
Phone
N/A
Web
N/A